ramilife hct 5 mg/25 mg tablete
actavis group ptc ehf. - hidroklorotiazid; ramipril - tableta - hidroklorotiazid 25 mg / 1 tableta ramipril5 mg / 1 tableta; ramipril 5 mg / 1 tableta - ramipril in diuretiki
ramilife hct 2,5 mg/12,5 mg tablete
actavis group ptc ehf. - hidroklorotiazid; ramipril - tableta - hidroklorotiazid 12,5 mg / 1 tableta ramipril2,5 mg / 1 tableta; ramipril 2,5 mg / 1 tableta - ramipril in diuretiki
ramilife hct 5 mg/25 mg tablete
actavis group ptc ehf. - hidroklorotiazid; ramipril - tableta - hidroklorotiazid 25 mg / 1 tableta ramipril5 mg / 1 tableta; ramipril 5 mg / 1 tableta - ramipril in diuretiki
ramilife hct 5 mg/25 mg tablete
actavis group ptc ehf. - hidroklorotiazid; ramipril - tableta - hidroklorotiazid 25 mg / 1 tableta ramipril5 mg / 1 tableta; ramipril 5 mg / 1 tableta - ramipril in diuretiki
ramilife hct 2,5 mg/12,5 mg tablete
actavis group ptc ehf. - hidroklorotiazid; ramipril - tableta - hidroklorotiazid 12,5 mg / 1 tableta ramipril2,5 mg / 1 tableta; ramipril 2,5 mg / 1 tableta - ramipril in diuretiki
ramilife hct 5 mg/12,5 mg tablete
actavis group ptc ehf. - hidroklorotiazid; ramipril - tableta - hidroklorotiazid 12,5 mg / 1 tableta ramipril5 mg / 1 tableta; ramipril 5 mg / 1 tableta - ramipril in diuretiki
ramilife hct 5 mg/12,5 mg tablete
actavis group ptc ehf. - hidroklorotiazid; ramipril - tableta - hidroklorotiazid 12,5 mg / 1 tableta ramipril5 mg / 1 tableta; ramipril 5 mg / 1 tableta - ramipril in diuretiki
ramilife hct 2,5 mg/12,5 mg tablete
actavis group ptc ehf. - hidroklorotiazid, ramipril - tableta - hidroklorotiazid 12,5 mg / 1 tableta; ramipril 2,5 mg / 1 tableta - ramipril in diuretiki
dynepo
shire pharmaceutical contracts limited - epoetin delta - kidney failure, chronic; anemia - antianemični preparati - zdravilo dynepo je indicirano za zdravljenje simptomatske anemije, povezane s kronično odpovedjo ledvic (crf) pri odraslih bolnikih. lahko se uporablja pri bolnikih na dializi, in pri bolnikih na dializi.
ertapenem sun
sun pharmaceutical industries (europe) b.v. - ertapenem natrij - bakterijske okužbe - ertapenem - treatmentertapenem sun is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4. 4 in 5. 1):- intra-abdominal infections- community acquired pneumonia- acute gynaecological infections- diabetic foot infections of the skin and soft tissue (see section 4. 4)preventionertapenem sun is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery (see section 4. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.